Patrick G. Enright
Director, Molecular Templates, Inc.
Companies
- Veradermics, IncBoard member Feb 3, 2026 to now1
- BioAge Labs, Inc.Board member Sep 25, 2024 to now2
- Zenas BioPharma, Inc.Board member Sep 12, 2024 to now3
- Vera Therapeutics, Inc.Board member May 13, 2021 to now4
- Jazz PharmaceuticalsBoard member Jul 9, 2009 to now5
- Aptinyx Inc.Board member Jun 20, 2018 to May 31, 20226
- Aimmune Therapeutics (United Kingdom)Board member Aug 5, 2015 to Oct 14, 20207
- Corcept TherapeuticsBoard member Apr 4, 2008 to Mar 20, 20178
- Esperion TherapeuticsBoard member Jun 25, 2013 to May 18, 20159
- SequenomBoard member Jun 8, 2006 to Jun 26, 200710
- Molecular Templates, Inc.Board member Mar 7, 2006 to Mar 2, 200711
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Veradermics, Inc MANE2,053,474 shares12$248.8M at $121.14Feb 5, 2026
- Vera Therapeutics, Inc. VERA3,602,475 shares13$104.6M at $29.04Dec 15, 2025
- Zenas BioPharma, Inc. ZBIO786,520 shares14$21.0M at $26.72Oct 14, 2025
- BioAge Labs, Inc. BIOA1,710,589 shares15$8.5M at $4.95Sep 27, 2024
- Jazz Pharmaceuticals JAZZ21,278 shares16$4.4M at $207.05Aug 31, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 31, 2026Shares withheld for tax 1,692 shares at $241.39 of Jazz Pharmaceuticals16
- Aug 31, 2026Shares withheld for tax 14 shares at $244.64 of Jazz Pharmaceuticals16
- Aug 5, 2026Granted 1,605 shares of Jazz Pharmaceuticals17
- Feb 5, 2026Bought 882,353 shares at $17.00 of Veradermics, Inc12
- Feb 5, 2026Bought 192,647 shares at $17.00 of Veradermics, Inc12
- Feb 5, 2026Converted 1,171,121 shares of Veradermics, Inc12
- Feb 5, 2026Converted 1,171,121 shares of Veradermics, Inc12
- Feb 5, 2026Converted 1,236,631 shares of Veradermics, Inc12
- Dec 11, 2025Bought 5,882 shares at $42.50 of Vera Therapeutics, Inc.13
- Oct 9, 2025Bought 11,990 shares at $20.85 of Zenas BioPharma, Inc.14
- Oct 9, 2025Bought 105,265 shares at $19.00 of Zenas BioPharma, Inc.14
- Aug 18, 2025Other 5,000 shares of Jazz Pharmaceuticals18
- Aug 8, 2025Shares withheld for tax 1,805 shares at $111.25 of Jazz Pharmaceuticals19
- Aug 7, 2025Granted 3,507 shares of Jazz Pharmaceuticals19
- Jun 24, 2025Bought 27,071 shares at $22.35 of Vera Therapeutics, Inc.20
- Jun 24, 2025Bought 13,536 shares at $22.35 of Vera Therapeutics, Inc.20
- Jun 23, 2025Bought 139,595 shares at $20.87 of Vera Therapeutics, Inc.20
- Jun 23, 2025Bought 69,798 shares at $20.87 of Vera Therapeutics, Inc.20
- Sep 27, 2024Bought 400,000 shares at $18.00 of BioAge Labs, Inc.15
- Sep 27, 2024Converted 1,310,589 shares of BioAge Labs, Inc.15
- Sep 16, 2024Bought 440,000 shares at $17.00 of Zenas BioPharma, Inc.21
- Sep 16, 2024Converted 334,530 shares of Zenas BioPharma, Inc.21
- Sep 16, 2024Converted 1,003,592 shares of Zenas BioPharma, Inc.21
- Sep 16, 2024Converted 723,812 shares of Zenas BioPharma, Inc.21
- Aug 2, 2024Granted 3,731 shares of Jazz Pharmaceuticals22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARVeradermics, Inc, Board member
- 2SEC EDGARBioAge Labs, Inc., Board member
- 3SEC EDGARZenas BioPharma, Inc., Board member
- 4
- 5SEC EDGARJazz Pharmaceuticals, Board member
- 6SEC EDGARAptinyx Inc., Board member
- 7
- 8SEC EDGARCorcept Therapeutics, Board member
- 9SEC EDGAREsperion Therapeutics, Board member
- 10SEC EDGARSequenom, Board member
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARForm 4 filed Aug 7, 2026
- 18SEC EDGARForm 4 filed Jan 8, 2026
- 19SEC EDGARForm 4 filed Aug 11, 2025
- 20SEC EDGARForm 4 filed Jun 25, 2025
- 21SEC EDGARForm 4 filed Sep 16, 2024
- 22SEC EDGARForm 4 filed Aug 6, 2024